🔍

DMCC - DMCC Speciality

📊 NSE: DMCC 🏢 Chemicals 📅 Last Updated: 12/13/2025 21:37

📢 Recent Corporate Announcements

DMCC Speciality Chemicals Confirms Non-Large Corporate Status for FY 2026

🟡 NEUTRAL ⭐ 2/10

REGULATORY 📅 27 Apr 2026, 05:07 PM

DMCC Speciality Chemicals Limited has submitted its initial disclosure to the stock exchanges regarding its corporate status. The company clarified that it does not meet the criteria to be classified as a 'Large Corporate' under the SEBI circular dated August 10, 2021. Consequently, the company is not mandated to raise 25% of its incremental borrowings through the issuance of debt securities. This is a routine annual compliance filing and does not reflect any change in the company's financial health or operations.

DMCC filed the initial disclosure pursuant to SEBI/HO/DDHS/P/CIR/2021/613 guidelines.
The company is officially identified as a 'Non-Large Corporate' for the assessment period.
Exemption from mandatory debt security issuance for incremental borrowings.
The filing was submitted to both NSE and BSE on April 27, 2026.

💡 No action is required as this is a standard regulatory filing. Investors should continue to monitor the company's quarterly financial performance and operational updates.

DMCC Clarifies No Undisclosed Information Behind Recent Share Price Surge

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 17 Apr 2026, 10:31 AM

DMCC Speciality Chemicals Limited has responded to a clarification request from the National Stock Exchange (NSE) regarding a significant increase in its share price. The company stated that it is in full compliance with SEBI (LODR) Regulations and has already disclosed all price-sensitive information. Management confirmed there are no undisclosed impending announcements or corporate actions that would impact the stock price. The company attributes the recent price movement to market-driven factors beyond its control.

Responded to NSE letter dated April 16, 2026, regarding significant price movement
Confirmed no undisclosed price-sensitive information or corporate actions exist
Stated full compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Attributed recent share price volatility to external market conditions

💡 As the company has confirmed no new material developments, investors should avoid speculative trading and focus on the company's fundamental financial performance.

DMCC Speciality Chemicals Announces Trading Window Closure from April 1, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 26 Mar 2026, 11:17 AM

DMCC Speciality Chemicals Limited has announced the closure of its trading window for all designated persons starting April 1, 2026. This action is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the company's Q4 and full-year financial results for the period ending March 31, 2026. The window will remain closed until 48 hours after the board meeting where the audited standalone and consolidated financial results are approved. The specific date for the board meeting will be communicated to the exchanges at a later time.

Trading window closure begins on April 1, 2026, for the quarter and year ending March 31, 2026.
Restriction applies to all designated persons and their immediate relatives as per SEBI regulations.
Window will reopen 48 hours after the declaration of audited standalone and consolidated financial results.
The board meeting date for the approval of FY 2026 results is yet to be announced.

💡 This is a routine regulatory filing and requires no immediate action from retail investors. Investors should watch for the upcoming board meeting date announcement to prepare for the company's annual financial performance results.

DMCC Faces Rs 2.48 Crore Legal Suit from Shipping Corporation of India

🟡 NEUTRAL ⭐ 4/10

LEGAL 📅 23 Mar 2026, 04:18 PM

Shipping Corporation of India (SCI) has initiated a commercial suit against DMCC Speciality Chemicals in the City Civil Court, Mumbai. The claim involves charges amounting to Rs. 2.48 crore plus interest for cleaning and restowing cargo during a voyage to Antwerp. While the litigation is in its initial stages, the company does not foresee any material impact on its business operations. Management believes the financial position remains stable despite the pending legal matter.

Shipping Corporation of India (SCI) filed a commercial suit against DMCC in Mumbai City Civil Court.
The total quantum of the claim is Rs. 2.48 Crore plus applicable interest for cargo-related services.
The dispute involves charges for cleaning, stowing, and restuffing at various ports during a voyage to Antwerp.
Management states the litigation will not have a material adverse effect on the company's financial position.

💡 Investors should monitor the legal proceedings, though the claim amount of Rs. 2.48 crore is relatively small and unlikely to impact the company's long-term valuation. No immediate action is required as operations remain unaffected.

DMCC Shareholders Approve MD & CEO Re-appointment and MoA/AoA Changes with 99.99% Majority

🟢 POSITIVE ⭐ 7/10

MANAGEMENT 📅 16 Mar 2026, 03:59 PM

DMCC Speciality Chemicals has successfully passed five key resolutions via postal ballot, all receiving over 99.99% shareholder support. A major outcome is the re-appointment of Bimal Lalitsingh Goculdas as MD and CEO for a three-year term effective April 1, 2026. Shareholders also approved the appointment of Saloni Jhaveri as an Independent Director and a salary revision for Executive Director Kuldeep Kumar Tiwari. Furthermore, the company received approval to modernize its Memorandum and Articles of Association, ensuring updated corporate governance frameworks.

Bimal Lalitsingh Goculdas re-appointed as MD & CEO for a 3-year term from April 2026 to March 2029.
All five resolutions passed with an overwhelming majority of approximately 99.99% of votes cast.
Shareholders approved the appointment of Saloni Jhaveri as an Independent Director.
The company received authorization to alter its Memorandum and adopt new Articles of Association.
A total of 13,039,108 votes were polled, accounting for 52.28% of the total shareholding.

💡 The strong shareholder support for leadership continuity and governance updates is a positive indicator of stability. Investors should remain confident in the current management's strategic direction for the upcoming 2026-2029 period.

DMCC Seeks Shareholder Approval for MD Re-appointment and Board Changes

🟡 NEUTRAL ⭐ 6/10

MANAGEMENT 📅 11 Feb 2026, 04:03 PM

DMCC Speciality Chemicals has initiated a postal ballot to seek shareholder approval for the re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a three-year term effective April 1, 2026. The company is also proposing the appointment of Saloni Jhaveri as a Women Independent Director for a five-year term and a revision in the remuneration of Executive Director Kuldeep Kumar Tiwari. Additionally, resolutions include the alteration of the Memorandum of Association and adoption of new Articles of Association. The e-voting process concludes on March 15, 2026, with results expected by March 17, 2026.

Re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a 3-year term (2026-2029)
Appointment of Saloni Jhaveri as Women Independent Director for a 5-year term starting January 2026
Revision of remuneration for Kuldeep Kumar Tiwari, Executive Director (Operations), effective April 1, 2026
Proposed updates to the Memorandum of Association (MoA) and Articles of Association (AoA)
E-voting period scheduled from February 13, 2026, to March 15, 2026

💡 Investors should support the resolutions to ensure leadership continuity, while keeping an eye on the specific details of the remuneration revision in the full explanatory statement.

DMCC Q3FY26 Revenue Up 28% YoY to ₹151 Cr; PAT Declines 22% on Margin Pressure

🔵 WATCH ⭐ 7/10

EARNINGS 📅 07 Feb 2026, 03:27 PM

DMCC reported a strong 27.81% YoY growth in revenue to ₹150.87 crore for Q3FY26, driven by the resumption of the Boron business and improved realisations. However, EBITDA margins contracted significantly by 543 bps to 9.87% as elevated sulphur costs and a higher revenue base impacted percentages. While quarterly PAT fell 21.64% YoY to ₹6.17 crore, the 9-month performance remains robust with 9MFY26 PAT up 30.68% at ₹19.67 crore. The company expects the Boron segment to contribute ₹125-150 crore in annual revenue moving forward.

Revenue from operations grew 27.81% YoY to ₹150.87 crore in Q3FY26.
EBITDA margins compressed by 543 bps YoY to 9.87% due to high raw material costs and pricing divergence.
Resumed Boron operations are projected to generate ₹125-150 crore in annual revenue.
9MFY26 PAT increased by 30.68% to ₹19.67 crore compared to ₹15.06 crore in 9MFY25.
Sustainability initiatives now contribute over 80% of the company's energy requirements through solar and waste heat recovery.

💡 Investors should monitor the stabilization of margins as the company navigates volatile sulphur prices and the full-scale ramp-up of the Boron business. The strong 9-month cumulative growth suggests underlying resilience despite the quarterly margin hit.

DMCC Re-appoints Bimal Goculdas as MD & CEO for 3 Years; Approves Q3 FY26 Results

🟡 NEUTRAL ⭐ 6/10

MANAGEMENT 📅 06 Feb 2026, 03:35 PM

DMCC Speciality Chemicals has approved the re-appointment of Bimal Lalitsingh Goculdas as Managing Director and CEO for a three-year term starting April 2026. The board also approved an increase in remuneration for Executive Director Kuldeep Kumar Tiwari and proposed significant updates to the company's Memorandum and Articles of Association to align with the Companies Act 2013. While the Q3 FY26 financial results were approved, the specific P&L figures were not detailed in the provided cover letter, though the auditor's review report was clean. These changes aim to provide better operational flexibility and governance alignment for the company.

Re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a 3-year term from April 1, 2026, to March 31, 2029.
Proposed increase in remuneration for Shri Kuldeep Kumar Tiwari, Executive Director (Operations), subject to postal ballot approval.
Comprehensive update of Memorandum of Association (MOA) and Articles of Association (AOA) to align with the Companies Act 2013.
Approval of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025.
The board meeting commenced at 1:00 p.m. and concluded at 3:05 p.m. on February 6, 2026.

💡 Investors should view the leadership continuity as a sign of stability for the company's long-term strategy. Monitor the upcoming Postal Ballot results and the detailed Q3 financial performance once fully released to assess operational growth.

DMCC Approves Q3 Results, Re-appoints CEO, and Proposes MOA/AOA Amendments

🟡 NEUTRAL ⭐ 6/10

BOARD_MEETING 📅 06 Feb 2026, 03:32 PM

DMCC Speciality Chemicals has approved its unaudited financial results for Q3 FY26 and announced the re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a three-year term starting April 2026. The board also proposed significant amendments to the Memorandum and Articles of Association (MOA/AOA) to align with the Companies Act 2013 and provide greater operational flexibility for future activities. Additionally, a remuneration increase for the Executive Director of Operations was approved, subject to shareholder consent. These moves indicate a focus on leadership continuity and regulatory compliance.

Re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a 3-year term from April 2026 to March 2029.
Proposed amendments to MOA Object and Liability clauses to align with Companies Act 2013 and enable future business flexibility.
Approval of remuneration increase for Kuldeep Kumar Tiwari, Executive Director (Operations), pending shareholder approval.
Consolidated results include subsidiary DMCC (Europe) GMBH, which contributed a nominal Rs 3.35 lacs to Q3 revenue.
Shareholder approval for management and regulatory changes to be sought via Postal Ballot.

💡 Investors should monitor the upcoming Postal Ballot notice for specific details on the expanded 'Object Clause' to identify potential new business segments. Leadership continuity is a positive sign for management stability.

DMCC Speciality Chemicals Approves Q3 FY26 Results and Re-appoints Bimal Goculdas as MD & CEO

🟡 NEUTRAL ⭐ 6/10

BOARD_MEETING 📅 06 Feb 2026, 03:21 PM

DMCC Speciality Chemicals has approved its unaudited financial results for the quarter ended December 31, 2025, alongside key leadership decisions. The board confirmed the re-appointment of Bimal Lalitsingh Goculdas as MD and CEO for a three-year term effective April 2026, ensuring management continuity. Additionally, the company is seeking shareholder approval to amend its Memorandum of Association (MOA) to provide greater operational flexibility for future business activities. While the main entity's specific profit figures were not detailed in the text, its European subsidiary reported a marginal profit of ₹0.86 lacs for the quarter.

Re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a 3-year term (2026-2029).
Proposed increase in remuneration for Kuldeep Kumar Tiwari, Executive Director (Operations).
Amendment of MOA 'Main Objects' clause to allow for future business expansion and flexibility.
Adoption of new Articles of Association (AOA) to align with the Companies Act, 2013.
Subsidiary DMCC (Europe) GMBH reported a net profit of ₹0.86 lacs for the quarter ended Dec 31, 2025.

💡 Investors should review the full financial statements once published to assess core profitability trends. The management continuity is a positive sign, but the proposed changes to the MOA objects clause should be monitored for signs of diversification into new business segments.

DMCC Updates Authorized KMPs for Materiality Disclosures Under SEBI Regulations

🟡 NEUTRAL ⭐ 3/10

MANAGEMENT 📅 10 Jan 2026, 02:23 PM

DMCC Speciality Chemicals Limited has updated its list of Key Managerial Personnel (KMP) authorized to determine the materiality of events and information for stock exchange disclosures. The Board of Directors approved this list during their meeting on January 10, 2026, in compliance with SEBI (LODR) Regulations. The authorized team includes the Managing Director & CEO, Sr. Executive Vice-President, and the CFO. Additionally, a new Company Secretary and Compliance Officer will join the authorized group effective January 27, 2026.

Board authorized 4 Key Managerial Personnel for materiality determinations on January 10, 2026
Shri Bimal Lalitsingh Goculdas (MD & CEO) and Shri Sunil Kumar Goyal (CFO) remain key contacts
Ms. Pallavi Pednekar appointed as Company Secretary & Compliance Officer effective January 27, 2026
Disclosure made under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements)

💡 This is a routine administrative update regarding corporate governance and compliance. No immediate action is required as it does not impact the company's financial performance.

DMCC Appoints Saloni Jhaveri as Independent Director and Pallavi Pednekar as Company Secretary

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 10 Jan 2026, 01:55 PM

DMCC Speciality Chemicals has announced two key leadership appointments following its board meeting on January 10, 2026. Ms. Saloni Jhaveri, who brings over 20 years of experience in M&A and private equity, has been appointed as an Independent Director for a five-year term. Additionally, Ms. Pallavi Pednekar, with 12 years of secretarial experience, will take over as Company Secretary and Compliance Officer starting January 27, 2026. These appointments are aimed at strengthening the company's corporate governance and strategic oversight.

Ms. Saloni Jhaveri appointed as Non-Executive Independent Director for a 5-year term until January 9, 2031
Ms. Pallavi Pednekar appointed as Company Secretary and Compliance Officer effective January 27, 2026
Ms. Jhaveri has over 20 years of experience in M&A and currently heads Investor Relations at NIIF
Ms. Pednekar brings 12 years of experience in legal and secretarial functions from firms like NGL Fine-Chem
The appointments were approved by the Board of Directors in a meeting held on January 10, 2026

💡 These are routine leadership changes focused on corporate governance and compliance. Investors should view this as a neutral development with no immediate impact on stock fundamentals.

DMCC Appoints Saloni Jhaveri as Independent Director and New Company Secretary

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 10 Jan 2026, 01:49 PM

DMCC Speciality Chemicals Limited has announced key leadership appointments following its board meeting on January 10, 2026. Ms. Saloni Jhaveri, an expert with over 20 years of experience in private equity and M&A, has been appointed as an Independent Director for a five-year term. Furthermore, Ms. Pallavi Pednekar, who possesses 12 years of experience in secretarial and legal functions, will take over as Company Secretary and Compliance Officer starting January 27, 2026. These appointments are intended to bolster the company's corporate governance and strategic advisory capabilities.

Ms. Saloni Jhaveri appointed as Additional Independent Director for a 5-year term ending January 9, 2031.
Ms. Pallavi Pednekar appointed as Company Secretary and Compliance Officer effective January 27, 2026.
New Independent Director brings over 20 years of experience in M&A, corporate finance, and fundraising.
New Company Secretary has 12 years of experience, previously serving at NGL Fine-Chem Limited.

💡 These are routine management and governance updates. Investors should note the addition of M&A expertise to the board, which could be beneficial for future strategic initiatives.

DMCC Appoints Saloni Jhaveri as Independent Director and New Company Secretary

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 10 Jan 2026, 01:47 PM

DMCC Speciality Chemicals Limited has announced the appointment of Ms. Saloni Jhaveri as an Additional Non-Executive Independent Director for a five-year term starting January 10, 2026. Ms. Jhaveri brings over 20 years of experience in private equity and M&A, currently heading Investor Relations at NIIF. Furthermore, the company has appointed Ms. Pallavi Pednekar as the Company Secretary and Compliance Officer, effective January 27, 2026. These appointments are intended to strengthen the board's expertise and ensure robust regulatory compliance.

Ms. Saloni Jhaveri appointed as Independent Director for a 5-year term until January 9, 2031
Ms. Pallavi Pednekar appointed as Company Secretary and Compliance Officer effective January 27, 2026
Ms. Jhaveri has over 20 years of experience in M&A and corporate finance across India and the US
Ms. Pednekar brings 12 years of experience in secretarial and legal functions from firms like NGL Fine-Chem

💡 These are routine leadership appointments and do not necessitate any immediate change in investment stance. Investors should view the addition of an experienced M&A professional to the board as a positive step for corporate governance.

DMCC Speciality Chemicals Submits SEBI Regulation 74(5) Compliance Certificate for Q3 FY2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 07 Jan 2026, 11:21 AM

DMCC Speciality Chemicals Limited has filed its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate, issued by MUFG Intime India Private Limited, confirms that all dematerialization requests for the quarter ended December 31, 2025, were processed within prescribed timelines. It further verifies that security certificates were mutilated, cancelled, and the depository names were updated in the register of members. This filing is a standard procedural requirement to ensure the accuracy of electronic shareholding records.

Compliance certificate submitted for the quarter ended December 31, 2025.
Confirmation that dematerialization requests were processed and listed on stock exchanges where earlier securities are listed.
Verification that physical certificates were mutilated and cancelled after due verification by the depository participant.
The Registrar and Share Transfer Agent (RTA) involved is MUFG Intime India Private Limited (formerly Link Intime).

💡 This is a routine regulatory filing confirming administrative compliance; no action is required from investors as it does not impact company fundamentals.

View All DMCC Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Revenue grew 26% YoY in 9MFY25 to INR 306 Cr. In FY23, bulk chemicals grew 18% and contributed 47-48% of total sales (INR 184.6 Cr), while specialty chemicals contributed the remaining 52-53%.

Geographic Revenue Split

The company serves both domestic and overseas markets across various geographies, though the specific percentage split between regions is not disclosed in available documents.

Profitability Margins

PAT margins were 3.51% in FY24 (INR 11.59 Cr), up from 1.80% in FY23 (INR 6.93 Cr), but down from 6.55% in FY22 (INR 21.36 Cr). Operating margins have been volatile, ranging from 8.8% to 23.6% over the last five years.

EBITDA Margin

EBITDA margin was 13.69% in 9MFY25, an improvement from 10.60% in Q1FY25 and 8.8% in FY23. The company expects to maintain operating margins between 13% and 14% over the medium term.

Capital Expenditure

The company has no major debt-funded capex plans over the medium term, as recent 'enhanced capacities' are already expected to support business profile growth.

Credit Rating & Borrowing

CRISIL Ratings maintains a 'Stable' outlook. Bank loan facilities were recently enhanced from INR 105 Cr to INR 125 Cr, with bank limit utilization low at approximately 39% to 49.38% in 2024.

⚙️ Operational Drivers

Raw Materials

Major raw materials include sulfur, benzene, ethanol, and boron, which collectively account for 60-65% of total sales costs.

Capacity Expansion

Current capacity is described as 'enhanced' following previous expansions; no specific MTPA figures or new planned expansion timelines are provided for the medium term.

Raw Material Costs

Raw material costs represent 60-65% of revenue. Profitability is highly susceptible to price fluctuations in these inputs, with a limited ability to pass on costs in the bulk chemical segment (48% of sales).

Manufacturing Efficiency

Manufacturing efficiency is supported by three decades of promoter experience and plants located in Roha (Maharashtra) and Dahej (Gujarat).

📈 Strategic Growth

Expected Growth Rate

21-24%

Growth Strategy

Growth will be achieved by utilizing recently enhanced capacities, focusing on higher-margin specialty chemicals (8 key products), and leveraging established market positions in sulfur and ethanol chemistry to reach an estimated FY25 revenue of INR 400-410 Cr.

Products & Services

Sulphuric acid, specialty and commodity chemicals based on sulphur, ethanol, and boron chemistries.

Brand Portfolio

Ship brand (formerly used for phosphate fertilizers).

New Products/Services

The company recently achieved higher realizations from Boron products, contributing to a 13.69% EBITDA in 9MFY25.

Market Expansion

The company is expanding its presence in domestic and overseas markets through its established relations with reputed clients across geographies.

Strategic Alliances

Borax Morarji Ltd was amalgamated with DMCC effective April 01, 2016, to consolidate the chemical business.

🌍 External Factors

Industry Trends

The industry is shifting toward specialty chemicals to stabilize margins; DMCC is positioning itself with 8 specialty products to counter the volatility of its 4 bulk chemical products, aiming for a 13-14% operating margin.

Competitive Landscape

High competition exists in the commodity/bulk chemical segments, while specialty segments offer more protected margins.

Competitive Moat

The moat is based on a 100+ year history (incorporated 1919), status as a pioneer in sulphuric acid, and a diversified portfolio that allays sectoral concentration risks.